The new Canadian guideline presents evidence-based recommendations for prescribing of opioids for chronic non-cancer pain, including maximum dose recommendations, avoiding opioids in high-risk populations, and guidance for tapering.
Jason Busse, Associate Professor in the Department of Anesthesia at McMaster University and researcher with the Michael G. DeGroote National Pain Centre in Hamilton, Ontario, co-authored the guideline (open access). In this podcast, he speaks with Dr. Diane Kelsall, interim editor-in-chief, CMAJ, and explains the recommendations.
Listen to the author interview:
Dr. Matthew Stanbrook, deputy editor of CMAJ, interviews Dr. Danielle Martin, family physician and VP of Medical Affairs and Health System Solutions at Women's College Hospital in Toronto (and she made headlines last year when she eloquently defended our healthcare system in front of the US Senate during the Obamacare debate).
Dr. Martin and co-authors (Steven Morgan, Michael Law, Jamie R. Daw, Liza Abraham) say that implementing universal public coverage of prescription drugs in Canada would be estimated to reduce total spending by $7.2 billion while increasing government costs by only $1.0 billion. This economic modeling study shows that universal public drug coverage could be implemented without substantially increasing government spending.
Read full article.
Subscribe to CMAJ Podcasts on iTunes, Stitcher, Overcast, Instacast, or your favourite aggregator. You can also follow us directly on our SoundCloud page. Our podcasts are also released on cmaj.ca and here on the blogs.